Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.

Histopathology - 1 Apr 1999

Nakopoulou L, Michalopoulou A, Giannopoulou I, Tzonou A, Keramopoulos A, Lazaris A C, Davaris P S

Abstract excerpt

AIM: A role for altered programmed cell death in cancer stems from the description of alterations on tumour-associated genes involved in the regulation of apoptosis such as p53 and bcl-2. The balance between the latter may have significant implications for the pathobiology of breast cancer. This study was therefore undertaken to evaluate the expression of these two gene products with opposite functions. METHODS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Carcinoma, Ductal, Breast

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma in Situ

Share to Carcinoma, Lobular

Share to Immunohistochemistry

Share to Predictive Value of Tests

Share to Proto-Oncogene Proteins c-bcl-2

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 10231398
DOI: 10.1046/j.1365-2559.1999.00627.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.PMID 10231398Read ↗

Regulators of apoptosis in human breast cancer.Semantic proximity Read ↗

The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer.Semantic proximity Read ↗

Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma.Semantic proximity Read ↗

c-myc, p53 andbcl-2, apoptosis-related genes in infiltrating breast carcinomas: Evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patientsSemantic proximity Read ↗

Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group.Semantic proximity Read ↗

[Different phenotypes generated by changes in bcl-2 and p53 expression in breast cancer].Semantic proximity Read ↗

Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.Semantic proximity Read ↗

Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.Semantic proximity Read ↗

Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.Semantic proximity Read ↗

Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53Semantic proximity Read ↗

Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.Semantic proximity Read ↗

Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.